| Identification | Back Directory | [Name]
Tricyclo[3.3.1.13,7]decane-2-carboxylic acid, 2-[[[5-(2,6-dimethoxyphenyl)-1-[2-(1-methylethyl)-4-[[methyl[3-[methyl[3-(methylamino)propyl]amino]propyl]amino]carbonyl]phenyl]-1H-pyrazol-3-yl]carbonyl]amino]- | [CAS]
1613265-52-3 | [Synonyms]
Tricyclo[3.3.1.13,7]decane-2-carboxylic acid, 2-[[[5-(2,6-dimethoxyphenyl)-1-[2-(1-methylethyl)-4-[[methyl[3-[methyl[3-(methylamino)propyl]amino]propyl]amino]carbonyl]phenyl]-1H-pyrazol-3-yl]carbonyl]amino]- | [Molecular Formula]
C42H58N6O6 | [MOL File]
1613265-52-3.mol | [Molecular Weight]
742.95 |
| Hazard Information | Back Directory | [Uses]
SR 142948-C3-NHMe is the methylated SR 142948 (HY-107664). | [References]
[1] Renard E, et al. Positron Emission Tomography Imaging of Neurotensin Receptor-Positive Tumors with 68Ga-Labeled Antagonists: The Chelate Makes the Difference Again. J Med Chem. 2021 Jun 24;64(12):8564-8578. DOI:10.1021/acs.jmedchem.1c00523 |
|
| Company Name: |
TargetMol
|
| Telephone: |
400-821-0310 15002144251 |
| Website: |
www.targetmol.cn/ |
|